Literature DB >> 16622849

Matrix metalloproteinases and cellular motility in development and disease.

Michael N VanSaun1, Lynn M Matrisian.   

Abstract

The movement of cells and the accompanied remodeling of the extracellular matrix is a critical step in many developmental processes. The matrix metalloproteinases (MMPs) are well recognized as mediators of matrix degradation, and their activity as regulators of signaling pathways by virtue of the cleavage of nonmatrix substrates has been increasingly appreciated. In this review, we focus on the role of MMPs in altering processes that influence cellular motility. MMP involvement in cellular adhesion, lamellipodia-directed movement, invadopodial protrusion, axonal growth cone extension, and chemotaxis are discussed. Although not designed to be comprehensive, these examples clearly demonstrate that cellular regulation of the MMPs influences cell motility in a variety of ways, including regulating cell-cell interactions, cell-matrix interactions, matrix degradation, and the release of bioactive signaling molecules. Deregulation of these interactions can ultimately result in disorders including inflammatory diseases, vascular diseases, bone diseases, neurological disorders, and cancer. Copyright 2006 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16622849     DOI: 10.1002/bdrc.20061

Source DB:  PubMed          Journal:  Birth Defects Res C Embryo Today        ISSN: 1542-975X


  21 in total

1.  Antagonistic enzymes may generate alternate phase transitions leading to ephemeral gels.

Authors:  Sébastien Giraudier; Véronique Larreta-Garde
Journal:  Biophys J       Date:  2007-04-27       Impact factor: 4.033

2.  Complete reversal of epithelial to mesenchymal transition requires inhibition of both ZEB expression and the Rho pathway.

Authors:  Shreyas Das; Bryan N Becker; F Michael Hoffmann; Janet E Mertz
Journal:  BMC Cell Biol       Date:  2009-12-21       Impact factor: 4.241

3.  Deficiency of matrix metalloproteinase-13 increases inflammation after acute lung injury.

Authors:  Anita I Sen; Takayuki Shiomi; Yasunori Okada; Jeanine M D'Armiento
Journal:  Exp Lung Res       Date:  2010-09-23       Impact factor: 2.459

4.  Update analysis of studies on the MMP-9 -1562 C>T polymorphism and cancer risk.

Authors:  Li-Feng Zhang; Yuan-Yuan Mi; Qiang Cao; Wei Wang; Chao Qin; Jun-Feng Wei; Yao-Jun Zhou; Yong-Fei Li; Min Tang; Wei-Min Liu; Wei Zhang; Jian-Gang Zou
Journal:  Mol Biol Rep       Date:  2011-06-30       Impact factor: 2.316

5.  MMPs initiate Schwann cell-mediated MBP degradation and mechanical nociception after nerve damage.

Authors:  Hideo Kobayashi; Sharmila Chattopadhyay; Kinshi Kato; Jennifer Dolkas; Shin-Ichi Kikuchi; Robert R Myers; Veronica I Shubayev
Journal:  Mol Cell Neurosci       Date:  2008-09-05       Impact factor: 4.314

6.  Alterations in osteoclast function and phenotype induced by different inhibitors of bone resorption--implications for osteoclast quality.

Authors:  Anita V Neutzsky-Wulff; Mette G Sørensen; Dino Kocijancic; Diana J Leeming; Morten H Dziegiel; Morten A Karsdal; Kim Henriksen
Journal:  BMC Musculoskelet Disord       Date:  2010-06-01       Impact factor: 2.362

7.  MMP1, 2, 3, 7, and 9 gene polymorphisms and urinary cancer risk: a meta-analysis.

Authors:  Liu Tao; Zuo Li; Li Lin; Yin Lei; Yu Hongyuan; Jing Hongwei; Liu Yang; Kong Chuize
Journal:  Genet Test Mol Biomarkers       Date:  2015-08-24

8.  SH2B1beta (SH2-Bbeta) enhances expression of a subset of nerve growth factor-regulated genes important for neuronal differentiation including genes encoding urokinase plasminogen activator receptor and matrix metalloproteinase 3/10.

Authors:  Linyi Chen; Travis J Maures; Hui Jin; Jeffrey S Huo; Shafaat A Rabbani; Jessica Schwartz; Christin Carter-Su
Journal:  Mol Endocrinol       Date:  2007-10-18

9.  Active MMP-2 effectively identifies the presence of colorectal cancer.

Authors:  Mary Jo Murnane; Jinguo Cai; Sania Shuja; David McAneny; Veronica Klepeis; John B Willett
Journal:  Int J Cancer       Date:  2009-12-15       Impact factor: 7.396

10.  A/G polymorphism of matrix metalloproteinase 7 gene promoter region and cancer risk: A meta-analysis.

Authors:  Jing Wu; Xuan Guan; Kui Zhang; Ya-Ting Li; Peng Bai; Jin Wu
Journal:  Biomed Rep       Date:  2013-07-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.